Navigation Links
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
Date:12/21/2007

website is http://www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and development of products. Various important risks may cause the Company's actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contacts:

Jennifer Snyder (media) Kyle Kuvalanka (investors)

(617) 448-0281 (857) 498-0818


'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
2. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
3. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
4. 2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation
5. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
6. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
7. Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
9. Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA
10. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
11. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ralization ready at Passport .../ -- New vaccine requirements will affect,anyone w...o the U.S. and,anyone seeking adjustment of status...of of vaccinations against vaccine-preventable dis...ee on Immunization Practices.,Passport Health, a c...
(Date:7/23/2008)...rm count, motility, study finds , , THUR...lly invasive procedure can treat a common cause of...f having a baby, a new study finds. , The condi...lood vessels in the scrotum which prevents the nor...testicles. A minimally invasive radiological proce...
(Date:7/23/2008)...may be tough, but,Hollywood,s young stars like Lan...ing new smile to boost confidence. Cosmetic dentis...nts beam in on success, citing his,experience that...nce they,need for stardom. In agreement is Landon ...e designed by Dr. Kosdon., MTV,s Rock The Cradle ...
(Date:7/23/2008)...rouble, the worse their performance , , ...en suffering from coronary heart disease seem to f...And the longer the person had had heart disease, t...as reasoning, vocabulary and verbal fluency, accor...ean Heart Journal . , The research, however, ha...
Breaking Medicine News(10 mins):Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
...a Corporation announced that, in conjunction with ...T), both parties have agreed for reasons of futil...) for the treatment of cystic fibrosis (CF). Genae...amine in prostate cancer, which is an investigator...
...li, daughter of Bangladeshi immigrants to the Unit...2007. Nora, 17, won the final competition, held i... than $60,000, The Daily Star said Wednesday, quot..."I just want to start a business and maybe even st...
...owth of Internet applications in healthcare has be...g increasingly involved in the healthcare service...acteristics that distinguish them from traditional...r in driving the use of the Internet in healthcare...
...en in Somerville town in Massachusetts are losing ... take notice. The kids of Somerville, a town of ...nutrition programme aimed at helping them learn he...hem throughout their lives. As a result the Somerv...
Other Medicine News:Health News:Genaera Discontinues Lomucin in Cystic Fibrosis Studies 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 2Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 3
(Date:7/23/2008)...InCode BioPharmaceutics, Inc.,an emerging biophar...st,results demonstrating the utility of their lead...e chronic blood disorder paroxysmal nocturnal,hemo...sented at the XXII,International Complement Worksh...e only treatment currently available for PNH patie...
(Date:7/22/2008)...nin Medical, a leading innovator,of physiological ...ntered,the clinical testing phase with its breakth...tion. Today,s most common application for this,tec...al blood oxygenation,in the brain -- cerebral oxim...going clinical study at the,Duke University Medica...
(Date:7/22/2008)...dra(R) Resulted in Significant, Reductions in A1C ...orithm Used, BRI...om the "Adjust to,Target in Type 2 Diabetes: Compa...ng for Adjustment of Mealtime Insulin Glulisine" s...ciation,s (ADA) medical journal,Diabetes Care. Th...
(Date:7/22/2008)...sis Technology in the European ...ewswire-FirstCall/ -- Cynosure, Inc.,(Nasdaq: CYN...ad array of,light-based aesthetic treatment system... MPX(TM), the company,s high-powered, dual-wavelen...en skin through collagen,remodeling. The CE Mark c...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Media Advisory Oncolytics Biotech Inc to Present at BIO InvestorForum 2007 1063 1Media Advisory Oncolytics Biotech Inc to Present at BIO InvestorForum 2007 1063 2MedImmune Announces Phase 2 Safety Data for Anti RSV Antibody and National RSV Surveillance Results 449 1MedImmune Announces Phase 2 Safety Data for Anti RSV Antibody and National RSV Surveillance Results 449 2MedImmune Announces Phase 2 Safety Data for Anti RSV Antibody and National RSV Surveillance Results 449 3MedImmune Announces Phase 2 Safety Data for Anti RSV Antibody and National RSV Surveillance Results 449 4What emotional memories are made of 2896 1What emotional memories are made of 2896 2The industrial space age 679 1The industrial space age 679 2
...ll-natural moisturizing mist for the eyes develope...thers, from Oregon Health Sciences University's Ca...TEARS (2000) and dry eye patients showed, on avera...he eyes' tear film without disrupting the tear fil...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and
This latest sensor array with 275 channels gives an average inter-channel spacing of just 2.2 cm. This high-density array is particularly useful when using advanced analysis techniques, such as Synt
...ement position is achieved using an increased tilt...tient bed. The patient preparation can be carried ...ency the patient can be brought rapidly outside th...he integrated neck support increases patient safet...
Medicine Products: